VELA Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.05M | Buy |
14,964
+2,116
| +16% | +$148K | 0.28% | 90 |
|
2025
Q1 | $944K | Sell |
12,848
-1,691
| -12% | -$124K | 0.3% | 94 |
|
2024
Q4 | $953K | Hold |
14,539
| – | – | 0.27% | 89 |
|
2024
Q3 | $1.13M | Sell |
14,539
-994
| -6% | -$77.4K | 0.35% | 88 |
|
2024
Q2 | $1.21M | Hold |
15,533
| – | – | 0.38% | 84 |
|
2024
Q1 | $1.05M | Buy |
15,533
+1,545
| +11% | +$105K | 0.36% | 86 |
|
2023
Q4 | $942K | Buy |
13,988
+811
| +6% | +$54.6K | 0.36% | 88 |
|
2023
Q3 | $892K | Buy |
13,177
+1,881
| +17% | +$127K | 0.39% | 85 |
|
2023
Q2 | $808K | Hold |
11,296
| – | – | 0.37% | 91 |
|
2023
Q1 | $784K | Buy |
11,296
+3,326
| +42% | +$231K | 0.36% | 88 |
|
2022
Q4 | $540K | Hold |
7,970
| – | – | 0.27% | 104 |
|
2022
Q3 | $437K | Buy |
7,970
+1,288
| +19% | +$70.6K | 0.25% | 108 |
|
2022
Q2 | $441K | Buy |
6,682
+897
| +16% | +$59.2K | 0.25% | 103 |
|
2022
Q1 | $384K | Buy |
5,785
+1,104
| +24% | +$73.3K | 0.24% | 104 |
|
2021
Q4 | $273K | Buy |
+4,681
| New | +$273K | 0.18% | 113 |
|